Category Archives: News
SAN DIEGO, FEBRUARY 17, 2014 – Daily Application of Alprostadil Topical Cream (Vitaros) Does Not Impact Vaginal pH, Flora, or Histology in Female Cynomolgus Monkeys. Click the PDF Icon for full details.
SAN DIEGO, MAY 19-20, 2014 – BTS Research attends The 2014 AAPS National Biotechnology Conference at the Sheraton Hotel and Marina.
SAN DIEGO, APRIL 14, 2014 – To better reflect company strengths and direction, BioQuant and BioTox Sciences will now operate under the name BTS Research. Our old names will continue to be legally binding.
BIO-QUANT ANNOUNCES THE EXPANSION OF ITS RESEARCH ANIMAL DIAGNOSTIC SERVICES TO COVER ALL NINE SPECIES.
SAN DIEGO, CA, September, 2008 –Bio-Quant Inc (“Bio-Quant”) the largest biotech Contract Research Organization (CRO) in San Diego, announced today the expansion of its animal diagnostic services division to cover all nine species used in research.
Dr. Bassam Damaj, Chief Executive Officer of Bio-Quant, said, “Animal welfare is of great importance, and Bio-Quant is very pleased to announce the expansion of its Research Animal Diagnostic Services. Bio-Quant is the only local facility providing this high quality service to the San Diego community, and we will continue to grow our capabilities in this area to support our client’s needs. This marks the completion of our planned expansion program that we have been implementing over the last couple of years”
He added, “Our laboratory covers comprehensive clinical chemistry, hematology, coagulation, blood gas analysis, urine analysis for all nine species. The advanced equipments used at Bio-Quant allows the analysis of full CBC with only 15uL of blood as opposed to the 100uL required by most laboratories allowing researchers to run multiple CBCs during their experimental studies without affecting the health status of the animals.”
Other specialty services are also provided worldwide by Bio-Quant such as Elisa, FACS analysis, protein electrophoresis, and gel electrophoresis as well as in vitro cellular functional assays.
About Bio-Quant, Inc.
Bio-Quant, Inc. is a profitable revenue-generating biotechnology pre-clinical contract research organization specializing in in vitro and in vivo pharmacology, PK and toxicology to support non-GLP pre-IND enabling studies in addition to vivarium housing services. The company is based in San Diego, California with 20,000 sq ft office and laboratory facilities. The company specializes in pre-clinical work in the areas of Inflammation, Oncology, and Immunology, PK and toxicology services.
More information is available at : www.bio-quant.com
Bio3 Research S.r.l. (Milano – Italy), is pleased to announce the positive preclinical studies outcome (conducted by the CRO Bio-Quant Inc. La Jolla/CA) obtained with HMGB1 in wound healing in mice and pigs (Vehicle and PDGF as control) which confirms the protein high potential in tissue remodeling. HMGB1 project has demonstrated in-vitro and in-vivo the dual ability of the protein to accelerate the wound healing process and to control the remodeling of collagen and fibroblasts. Bio3 Research has also tested in animals (rabbits) HMGB1 for its use in cartilage repair with encouraging results.